Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
Deals-lir
Subscribe today for access to
Articles and Reports
Dx Deals: Labcorp Acquires Stake in European Testing Giant
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
Invitae-ArcherDX Merger to Create Precision Oncology Powerhouse
...
Already a member? Log in here
Thermo Fisher Acquisition of Qiagen Remains on Track
...
Already a member? Log in here
Danaher Closes $21.4 Billion GE Biopharma Acquisition
...
Already a member? Log in here
How Curative & KorvaLabs Created a Successful COVID-19 Testing Lab in Less than a Month
...
Already a member? Log in here
Labs, Universities and Even Computer Companies Target Point-of-Care COVID-19 Test Development
...
Already a member? Log in here
Diagnostic Deals: Urgent Need for Coronavirus Diagnostics Fuels Strategic Collaboration
...
Already a member? Log in here
Diagnostic Deals: Urgent Need for Coronavirus Diagnostics Fuels Strategic Collaboration
...
Already a member? Log in here
Diagnostic Deals: Lab Corp & Quest to Continue Targeting Small and Independent Labs for Acquisition
PAMA price cuts were supposed to drive consolidation in the lab market. The expectation was that price pressures would make it impossible for smaller labs to remain independent, rendering them juicy targets for the likes of
Industry Buzz: The 10 Biggest DX Mergers of 2019
Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A diagnostics deals that did come off in 2019.